JOHN PETERS
Allopathic & Osteopathic Physicians|Dermatology CRESTVIEW, FL NPI 1013004860
Browse related groups: Allopathic & Osteopathic Physicians|Dermatology FL Amgen Inc. All categories
General Payments — all program years on this page
$598.89
- Category: General Payments
- Program years: PY2020–2024
- Record count: 31
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $166.90 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $166.90 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $58.17 | 3 |
| Janssen Biotech, Inc. | $31.65 | 1 |
| ABBVIE INC. | $27.07 | 1 |
| Incyte Corporation | $17.69 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $17.57 | 1 |
| Galderma Laboratories, L.P. | $14.75 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078410277 | Janssen Biotech, Inc. | $31.65 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105246935 | ABBVIE INC. | $27.07 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117352265 | Amgen Inc. | $13.70 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117352267 | Amgen Inc. | $22.85 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117352269 | Amgen Inc. | $21.62 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141288324 | Incyte Corporation | $17.69 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1145321331 | Galderma Laboratories, L.P. | $14.75 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1152162505 | SUN PHARMACEUTICAL INDUSTRIES INC. | $17.57 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.